Pharmaceutical health policies constitute the regulatory framework and guidelines that govern the pharmaceutical sector, ensuring its responsible and ethical functioning. These policies are designed to safeguard public health by addressing various aspects of drug development, manufacturing, distribution, and consumption.
One key facet of pharmaceutical health policies is the regulation of drug approval processes, ensuring that medications undergo rigorous evaluations for safety, efficacy, and quality before reaching the market. These policies also encompass pricing and reimbursement strategies to promote affordability and accessibility of essential medications.
Furthermore, pharmaceutical health policies play a pivotal role in overseeing the ethical promotion and marketing of drugs, preventing deceptive practices and ensuring that information provided to healthcare professionals and the public is accurate and unbiased.
In the context of global health, these policies address issues of intellectual property, trade agreements, and equitable access to medications. They contribute to the development of a robust pharmacovigilance system, monitoring and addressing adverse drug reactions to enhance overall drug safety. Overall, these policies form the backbone of a healthcare system that prioritizes patient well-being, ethical practices, and equitable access to safe and effective pharmaceuticals.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India